A quantitative structure–activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1
暂无分享,去创建一个
[1] Eamonn F. Healy,et al. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .
[2] Feng Xu,et al. Model reactions related to cytochrome P-450. Effects of alkene structure on the rates of epoxide formation , 1988 .
[3] F. Guengerich,et al. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.
[4] T. Aoyama,et al. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. , 1994, Chemical research in toxicology.
[5] R. Schreiber,et al. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. , 1995, The Journal of pharmacology and experimental therapeutics.
[6] Jeffrey P. Jones,et al. Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] Slobodan Petar Rendic,et al. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.
[8] M H Tarbit,et al. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate. , 1998, Chemico-biological interactions.
[9] N. Chauret,et al. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[10] T. Walle,et al. Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase , 2000, Xenobiotica; the fate of foreign compounds in biological systems.
[11] G. Carlson,et al. Metabolism of styrene by human liver and lung. , 2000, Journal of toxicology and environmental health. Part A.
[12] M H Tarbit,et al. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. , 2000, Xenobiotica; the fate of foreign compounds in biological systems.
[13] S. Kežić,et al. Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[14] D. Lewis,et al. Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. , 2002, Toxicology.
[15] Michael M. Mysinger,et al. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[16] D. Lewis,et al. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[17] R. J. Nolan,et al. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human , 2005, Archives of Toxicology.